FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023946505> ?p ?o ?g. }

• W3023946505 endingPage "2557" @default.
• W3023946505 startingPage "2546" @default.
• W3023946505 abstract "To obtain baseline data for cervical cancer prevention in Japan, we analyzed human papillomavirus (HPV) data from 5045 Japanese women aged less than 40 years and diagnosed with cervical abnormalities at 21 hospitals during 2012-2017. These included cervical intraepithelial neoplasia grade 1 (CIN1, n = 573), CIN2-3 (n = 3219), adenocarcinoma in situ (AIS, n = 123), and invasive cervical cancer (ICC, n = 1130). The Roche Linear Array was used for HPV genotyping. The HPV type-specific relative contributions (RCs) were estimated by adding multiple infections to single types in accordance with proportional weighting attributions. Based on the comparison of type-specific RCs between CIN1 and CIN2-3/AIS/ICC (CIN2+), RC ratios were calculated to estimate type-specific risks for progression to CIN2+. Human papillomavirus DNA was detected in 85.5% of CIN1, 95.7% of CIN2-3/AIS, and 91.2% of ICC. Multiple infections decreased with disease severity: 42.9% in CIN1, 40.4% in CIN2-3/AIS, and 23.7% in ICC (P < .0001). The relative risk for progression to CIN2+ was highest for HPV16 (RC ratio 3.78, 95% confidence interval [CI] 3.01-4.98), followed by HPV31 (2.51, 1.54-5.24), HPV18 (2.43, 1.59-4.32), HPV35 (1.56, 0.43-8.36), HPV33 (1.01, 0.49-3.31), HPV52 (0.99, 0.76-1.33), and HPV58 (0.97, 0.75-1.32). The relative risk of disease progression was 1.87 (95% CI, 1.71-2.05) for HPV16/18/31/33/35/45/52/58, but only 0.17 (95% CI, 0.14-0.22) for HPV39/51/56/59/66/68. Human papillomavirus 16/18/31/33/45/52/58/6/11 included in a 9-valent vaccine contributed to 89.7% (95% CI, 88.7-90.7) of CIN2-3/AIS and 93.8% (95% CI, 92.4-95.3) of ICC. In conclusion, our data support the Japanese guidelines that recommend discriminating HPV16/18/31/33/35/45/52/58 genotypes for CIN management. The 9-valent vaccine is estimated to provide over 90% protection against ICC in young Japanese women." @default.
• W3023946505 created "2020-05-13" @default.
• W3023946505 creator A5004955803 @default.
• W3023946505 creator A5007032492 @default.
• W3023946505 creator A5010897098 @default.
• W3023946505 creator A5011627353 @default.
• W3023946505 creator A5016283232 @default.
• W3023946505 creator A5019577667 @default.
• W3023946505 creator A5026982152 @default.
• W3023946505 creator A5028795531 @default.
• W3023946505 creator A5032494359 @default.
• W3023946505 creator A5033422556 @default.
• W3023946505 creator A5042750898 @default.
• W3023946505 creator A5043373703 @default.
• W3023946505 creator A5054335379 @default.
• W3023946505 creator A5057771409 @default.
• W3023946505 creator A5058553514 @default.
• W3023946505 creator A5066806706 @default.
• W3023946505 creator A5071744194 @default.
• W3023946505 creator A5072585417 @default.
• W3023946505 creator A5076381033 @default.
• W3023946505 creator A5081861117 @default.
• W3023946505 creator A5082122917 @default.
• W3023946505 creator A5082910812 @default.
• W3023946505 creator A5087124471 @default.
• W3023946505 creator A5087493207 @default.
• W3023946505 creator A5090261374 @default.
• W3023946505 creator A5091086591 @default.
• W3023946505 date "2020-05-21" @default.
• W3023946505 modified "2023-10-01" @default.
• W3023946505 title "Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan" @default.
• W3023946505 cites W1553715500 @default.
• W3023946505 cites W1981725818 @default.
• W3023946505 cites W1987350137 @default.
• W3023946505 cites W2007245430 @default.
• W3023946505 cites W2019046770 @default.
• W3023946505 cites W2027826756 @default.
• W3023946505 cites W2095156171 @default.
• W3023946505 cites W2109836980 @default.
• W3023946505 cites W2114212562 @default.
• W3023946505 cites W2121732950 @default.
• W3023946505 cites W2126647170 @default.
• W3023946505 cites W2133525827 @default.
• W3023946505 cites W2139349670 @default.
• W3023946505 cites W2139736159 @default.
• W3023946505 cites W2161192994 @default.
• W3023946505 cites W2172748090 @default.
• W3023946505 cites W2193964353 @default.
• W3023946505 cites W2332665748 @default.
• W3023946505 cites W2889646458 @default.
• W3023946505 cites W2898173833 @default.
• W3023946505 cites W2902477821 @default.
• W3023946505 cites W2909223067 @default.
• W3023946505 cites W2915174157 @default.
• W3023946505 cites W2980111440 @default.
• W3023946505 cites W2993250673 @default.
• W3023946505 cites W2994980662 @default.
• W3023946505 cites W2995874980 @default.
• W3023946505 cites W3003341733 @default.
• W3023946505 cites W3023946505 @default.
• W3023946505 doi "https://doi.org/10.1111/cas.14445" @default.
• W3023946505 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7385338" @default.
• W3023946505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32372453" @default.
• W3023946505 hasPublicationYear "2020" @default.
• W3023946505 type Work @default.
• W3023946505 sameAs 3023946505 @default.
• W3023946505 citedByCount "21" @default.
• W3023946505 countsByYear W30239465052020 @default.
• W3023946505 countsByYear W30239465052021 @default.
• W3023946505 countsByYear W30239465052022 @default.
• W3023946505 countsByYear W30239465052023 @default.
• W3023946505 crossrefType "journal-article" @default.
• W3023946505 hasAuthorship W3023946505A5004955803 @default.
• W3023946505 hasAuthorship W3023946505A5007032492 @default.
• W3023946505 hasAuthorship W3023946505A5010897098 @default.
• W3023946505 hasAuthorship W3023946505A5011627353 @default.
• W3023946505 hasAuthorship W3023946505A5016283232 @default.
• W3023946505 hasAuthorship W3023946505A5019577667 @default.
• W3023946505 hasAuthorship W3023946505A5026982152 @default.
• W3023946505 hasAuthorship W3023946505A5028795531 @default.
• W3023946505 hasAuthorship W3023946505A5032494359 @default.
• W3023946505 hasAuthorship W3023946505A5033422556 @default.
• W3023946505 hasAuthorship W3023946505A5042750898 @default.
• W3023946505 hasAuthorship W3023946505A5043373703 @default.
• W3023946505 hasAuthorship W3023946505A5054335379 @default.
• W3023946505 hasAuthorship W3023946505A5057771409 @default.
• W3023946505 hasAuthorship W3023946505A5058553514 @default.
• W3023946505 hasAuthorship W3023946505A5066806706 @default.
• W3023946505 hasAuthorship W3023946505A5071744194 @default.
• W3023946505 hasAuthorship W3023946505A5072585417 @default.
• W3023946505 hasAuthorship W3023946505A5076381033 @default.
• W3023946505 hasAuthorship W3023946505A5081861117 @default.
• W3023946505 hasAuthorship W3023946505A5082122917 @default.
• W3023946505 hasAuthorship W3023946505A5082910812 @default.
• W3023946505 hasAuthorship W3023946505A5087124471 @default.
• W3023946505 hasAuthorship W3023946505A5087493207 @default.
• W3023946505 hasAuthorship W3023946505A5090261374 @default.
• W3023946505 hasAuthorship W3023946505A5091086591 @default.

• next